The specialist integrated CDMO

Browser not supported

Oops! Your browser version is not supported by our website.
Please use these following browsers to view this page:

Google Chrome

Knowledge Center

Inhaled ivermectin

Aug 04, 2022 US 20220241307

Dry powder inhaler formulation comparison: Study of the role of particle deposition pattern and dissolution

Sep 25, 2021 International Journal of Pharmaceutics (Amsterdam, Netherlands), September 25, 2021

Dry powder inhaler formulation of Cu,Zn-superoxide dismutase by spray drying: A proof-of-concept

May 06, 2021 Powder Technology, May 6, 2021

Developing and Characterizing DPI Formulations for Biologics

Apr 12, 2019 Pharma's Almanac, April 12, 2019

Biorelevant Dissolution Testing of Orally Inhaled Drugs

Apr 22, 2018 RDD 2018

Webinar - Dry Powder Inhaler Formulation Development

Apr 12, 2018 Webinar

Ultrasonic versus Two-Fluid Nozzle in a Spray Drying Process

Dec 06, 2017 DDL 2017

Spray Dried Composite Particles: Formulation and Process Parameters, Effect of two API Concentrations and Stability Assessment

Dec 06, 2017 DDL 2017

Dissolution of Orally Inhaled Drugs using DissolvIt®

Dec 06, 2017 DDL 2017

Effect of throat models and representative deposition profiles on the performance of carrier-based formulations

Dec 06, 2017 DDL 2017

Spray Dried Composite Particles: Formulation and Process Parameters, Effect of two API Concentrations and Stability Assessment

Nov 12, 2017 AAPS 2017

Paddle Over Disk as a Dissolution Test for Orally Inhaled Fluticasone Propionate

Nov 12, 2017 AAPS 2017